| GTO ID | GTC1033 |
| Trial ID | ChiCTR-OIC-16007996 |
| Disease | Malignant Pleural Mesothelioma | Pancreatic Carcinoma |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MESO CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Open-label, uncontrolled, single-arm pilot study to evaluate cellular immunotherapy using mesothelin-targeted chimeric antigen receptor engineered T cells in patients with mesothelin+ malignant pleural mesothelioma and pancreatic carcinoma. |
| Year | 2016 |
| Country | China |
| Company sponsor | Renji Hospital, Shanghai Jiao Tong University School of Medicine |
| Cohort 1 | |||||||
|
|||||||